Anxiety and dysautonomia symptoms in patients with a NaV1.7 mutation and the potential benefits of low-dose short-acting guanfacine.
de Cássia Collaço R, Lammens M, Blevins C, Rodgers K, Gurau A, Yamauchi S, Kim C, Forrester J, Liu E, Ha J, Mei Y, Boehm C, Wohler E, Sobreira N, Rowe PC, Valle D, Brock MV, Bosmans F.
de Cássia Collaço R, et al. Among authors: lammens m.
Clin Auton Res. 2024 Feb;34(1):191-201. doi: 10.1007/s10286-023-01004-1. Epub 2023 Dec 8.
Clin Auton Res. 2024.
PMID: 38064009